Sunflower Pharmaceutical Group Co.,Ltd (SHE:002737)

Market Cap	7.29B -30.5%
Revenue (ttm)	2.09B -52.8%
Net Income	-128.33M
EPS	-0.23
Shares Out	584.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.50 (4.00%)
Ex-Dividend Date	Jul 18, 2025

Volume	4,190,914
Average Volume	5,178,416
Open	12.46
Previous Close	12.49
Day's Range	12.23 - 12.58
52-Week Range	11.70 - 17.30
Beta	0.32
RSI	41.71
Earnings Date	Apr 27, 2026

About SHE:002737

Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. The company produces chemical and biological medicines, and health care products. It also provides products covering various therapeutic areas, including pediatrics, gynecology, adult digestive system, respiratory and cold, rheumatic bone disease, and cardiovascular and cerebrovascular; supplements; tonic; and antibiotics and children’s medicinal products. The company sells its pr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 5,727
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002737

Financial Performance

In 2024, SHE:002737's revenue was 3.38 billion, a decrease of -40.76% compared to the previous year's 5.70 billion. Earnings were 492.05 million, a decrease of -56.03%.